ASX Gems Conference 2024

Presentations & WebinarsAll
Written By Bradley Cocks

Our CEO Dr. Michael Baker talks about our biotechnology company, which is focused on developing a unique iNKT cell therapy platform to treat cancer. Watch now on-demand.

 
Bradley Cocks http://www.goodtrip.com.au
Previous

Arovella funded to Phase 1 data: completes $12.5m placement
Next

NWR Virtual Healthcare Conference